Marpai (MRAI) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
23 Nov, 2025Executive summary
National footprint enables servicing multi-state employers, differentiating from regional competitors.
Transformation from a traditional TPA to a technology-driven platform positions the company for future growth.
Operating expenses reduced by 70% year-over-year, saving $9.9 million as turnaround strategy accelerates.
Net loss for Q2 2025 was $4.4M, a significant improvement from $13.0M in Q2 2024, driven by lower costs and absence of impairment charges.
The company is exploring strategic alternatives, including potential investments, mergers, or a sale, to maximize shareholder value.
Financial highlights
Net revenues for Q2 2025 were $4.7 million, down 35% year-over-year.
Operating expenses for Q2 were $4.4 million, a 70% improvement over Q2 2024.
Net loss per share improved by $0.95 to $0.28 year-over-year.
Cash and cash equivalents at June 30, 2025, were $619,000, with restricted cash of $7.7 million.
Net cash used in operating activities for the first half of 2025 was $3.3 million, an improvement from $6.7 million in the prior year period.
Outlook and guidance
Revenue decline reflects strategic exit from unprofitable legacy contracts.
Management estimates profitability will be achieved in Q1 2026, supported by a strong new business pipeline for January 2026.
Major infrastructure investment planned for Q3 2025 to enhance efficiency and client service.
Management projects the need for additional capital to fund operations until revenue scales to self-sufficiency.
Substantial doubt exists about the company's ability to continue as a going concern over the next 12 months.
Latest events from Marpai
- Q2 2024 saw a 28% revenue drop, $13M net loss, and a $7.6M impairment charge.MRAI
Q2 20242 Feb 2026 - Q3 2024 losses narrowed as cost cuts offset revenue decline, but liquidity risks remain.MRAI
Q3 202415 Jan 2026 - Losses narrowed in 2024; new PBM products and partnerships target 2025 profitability.MRAI
Q4 202426 Dec 2025 - Board seeks approval for director elections, auditor ratification, and preferred stock authorization.MRAI
Proxy Filing2 Dec 2025 - Shareholders will vote on director elections, auditor ratification, and preferred stock authorization.MRAI
Proxy Filing2 Dec 2025 - Facing ongoing losses and liquidity risks, the company relies on new capital to sustain operations.MRAI
Registration Filing29 Nov 2025 - Revenue fell 27% to $5.4M; net loss improved, but liquidity and funding risks remain.MRAI
Q1 202519 Nov 2025 - Q3 2025 revenue fell 42%, but cost cuts and new funding drive a turnaround amid liquidity risks.MRAI
Q3 202517 Nov 2025